Human Norovirus: Experimental Models of Infection
AbstractHuman noroviruses (HuNoVs) are a leading cause of acute gastroenteritis worldwide. HuNoV infections lead to substantial societal and economic burdens. There are currently no licensed vaccines or therapeutics for the prevention or treatment of HuNoVs. A lack of well-characterized in vitro and in vivo infection models has limited the development of HuNoV countermeasures. Experimental infection of human volunteers and the use of related viruses such as murine NoV have provided helpful insights into HuNoV biology and vaccine and therapeutic development. There remains a need for robust animal models and reverse genetic systems to further HuNoV research. This review summarizes available HuNoV animal models and reverse genetic systems, while providing insight into their usefulness for vaccine and therapeutic development. View Full-Text
Share & Cite This Article
Todd, K.V.; Tripp, R.A. Human Norovirus: Experimental Models of Infection. Viruses 2019, 11, 151.
Todd KV, Tripp RA. Human Norovirus: Experimental Models of Infection. Viruses. 2019; 11(2):151.Chicago/Turabian Style
Todd, Kyle V.; Tripp, Ralph A. 2019. "Human Norovirus: Experimental Models of Infection." Viruses 11, no. 2: 151.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.